In this study, we want to asses the long-term safety of using a virus to deliver a gene, AAV2-hAQP1, and how effective this gene is at treating dry mouth in people who have received radiation therapy for head and neck cancer.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Xuguang Chen
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Head and Neck)
24-2380